NTRA
Natera, Inc.NASDAQHealthcare$207.98+2.35%ClosedMarket Cap: $29.48B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
16.61
P/S
12.78
EV/EBITDA
-110.97
DCF Value
$-314.93
FCF Yield
0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
64.8%
Operating Margin
-13.4%
Net Margin
-9.0%
ROE
-15.3%
ROA
-10.4%
ROIC
-11.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $665.5M | 67.1% | $-22.8M | $47.3M | $0.35 | — |
| FY 2025 | $2.31B | 64.8% | $-309.9M | $-208.2M | $-1.52 | — |
| Q3 2025 | $592.2M | 64.9% | $-97.6M | $-87.5M | $-0.64 | — |
| Q2 2025 | $546.6M | 63.5% | $-110.4M | $-100.9M | $-0.74 | — |
| Q1 2025 | $501.8M | 63.2% | $-79.2M | $-66.9M | $-0.50 | — |
| Q4 2024 | $476.1M | 62.9% | $-64.7M | $-53.8M | $-0.41 | — |
| FY 2024 | $1.70B | 60.3% | $-222.3M | $-190.4M | $-1.53 | — |
| Q3 2024 | $439.8M | 61.8% | $-39.3M | $-31.6M | $-0.26 | — |
| Q2 2024 | $413.4M | 58.8% | $-43.9M | $-37.5M | $-0.30 | — |
| Q1 2024 | $367.7M | 56.7% | $-74.3M | $-67.6M | $-0.56 | — |
| Q4 2023 | $311.1M | 51.4% | $-84.5M | $-78.0M | $-0.65 | — |
| FY 2023 | $1.08B | 45.5% | $-446.2M | $-434.8M | $-3.78 | — |